OakChart

Omeros Corp

OMERHealthcare·Biotechnology·USA·Small·NASD·Nov 11 • 3:59 PM ET

18.15+0.85 (4.91%)
2026-11-12 02:01 CET
Market cap
1,252.32 USD m
Revenue, TTM
38.42 USD m
Net income, TTM
124.83 USD m
Free cash flow, TTM
-75.11 USD m
EPS diluted, TTM
1.44
P/E
12.62
Compare

Price

OMER against its 20, 50 and 200-day averages
2050200beatearnings
10.0015.0020.006.7M13.4MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26OMERclose 18.1520-day 17.4050-day 18.32200-day 13.7118.1552w high52w low

14.5% under the 52-week high of 21.24 on 22 Sep 2026. 52-week low 6.24 on 13 Nov 2025. Last 15 sessions, 19.4% high to low

Volume 0.47× normal · the line is the 50-bar volume average

Profile

OMER
52-week range, 79% of the way up
6.2421.24

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

IndexRUT
Employees175
IPOOct 08, 2009
Beta3.00
ATR, 14d0.90
Rel volume0.47
Short float18.52%
Insider own4.29%
Inst own49.43%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.31B
Enterprise Value1.48B
Income124.83M
Sales38.42M
Book/sh-0.71
Cash/sh1.82
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees175
IPOOct 08, 2009

Ratios

P/E12.62
Forward P/E17.17
PEG-
P/S34.20
P/B-
P/C9.96
P/FCF-
EV/EBITDA-
EV/Sales38.49
Quick Ratio1.94
Current Ratio1.95
Debt/Eq-
LT Debt/Eq-
Option/ShortYes / Yes

Earnings

EPS (ttm)1.44
EPS next Y1.06
EPS next Q0.02
EPS this Y1750.00%
EPS next Y28.15%
EPS next 5Y-
EPS past 3/5Y- 53.45%
Sales past 3/5Y- -
EPS Y/Y TTM181.47%
Sales Y/Y TTM-
EPS Q/Q134.01%
Sales Q/Q-
EarningsNov 16 AMC
EPS/Sales Surpr.155.91% 124.79%

Ownership

Insider Own4.29%
Insider Trans-3.82%
Inst Own49.43%
Inst Trans8.50%
ROA47.82%
ROE-
ROIC67.05%
Gross Margin94.02%
Oper. Margin-189.53%
Profit Margin324.88%
SMA204.34%
SMA50-0.91%
SMA20032.40%
Trades-

Technical

Shs Outstand72.09M
Shs Float69.28M
Short Float18.52%
Short Ratio7.90
Short Interest12.83M
52W High21.24 -14.55%
52W Low6.24 190.87%
Volatility5.35% 5.27%
ATR (14)0.90
RSI (14)52.53
Beta3.00
Rel Volume0.47
Avg Volume1.63M
Volume756,999

Performance

Perf Week-0.17%
Perf Month-3.87%
Perf Quarter4.61%
Perf Half Y26.22%
Perf YTD5.68%
Perf Year163.43%
Perf 3Y1352.00%
Perf 5Y121.61%
Perf 10Y43.48%
Recom1.50
Target Price36.67
Prev Close17.30
Price18.15
Change %4.91%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Sep 22, 2026UpgradeCCantor FitzgeraldNeutral → Overweight$22+21.2%
Jun 10, 2025InitiatedHH.C. WainwrightBuy$9-50.4%
Dec 23, 2024InitiatedDD. Boral CapitalBuy$36+98.3%
Nov 14, 2024InitiatedRRodman & RenshawBuy$9-50.4%
Dec 08, 2022DowngradeUUBSBuy → Neutral$12 → $2-89.0%
Nov 08, 2022DowngradeBBofA SecuritiesNeutral → Underperform$8 → $3-83.5%
Jun 08, 2022DowngradeBBofA SecuritiesBuy → Neutral$12 → $4-78.0%
Oct 08, 2021DowngradeJJP MorganNeutral → Underweight
Oct 01, 2021DowngradeWWedbushNeutral → Underperform
Oct 01, 2021DowngradeMMaxim GroupBuy → Hold

Peers

Mkt cap
TickerCompanyMkt cap
ANNXAnnexon Inc794.34M
DNTHDianthus Therapeutics Inc5.03B
ZBIOZenas Biopharma Inc1.95B
ADMAAdma Biologics Inc2.93B
GERNGeron Corp657.13M
RAREUltragenyx Pharmaceutical Inc1.70B
RLYBRallybio Corp85.07M
PHARPharming Group NV ADR948.45M
AKTXAkari Therapeutics Plc ADR13.04M
CTXRCitius Pharmaceuticals Inc13.20M

Insider trading

latest 14 of 38
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Borges David J.VP, Finance & CAOSep 23 '26Option Exercise15.5810,000155,80010,000Sep 24 09:00 PM
Borges David J.VP, Finance & CAOSep 22 '26Option Exercise3.4410,00034,35010,000Sep 24 09:00 PM
Borges David J.VP, Finance & CAOSep 23 '26Sale20.9510,000209,5000Sep 24 09:00 PM
Borges David J.VP, Finance & CAOSep 22 '26Sale20.9510,000209,5000Sep 24 09:00 PM
DAVID BORGESOfficerSep 23 '26Proposed Sale21.0514,927314,213Sep 23 04:20 PM
DAVID BORGESOfficerSep 22 '26Proposed Sale18.4910,000184,900Sep 22 04:15 PM
Cancelmo Peter BVP, General CounselAug 28 '26Option Exercise2.9425,00073,50025,200Sep 01 04:41 PM
Cancelmo Peter BVP, General CounselAug 31 '26Option Exercise2.9425,00073,50025,200Sep 01 04:41 PM
Cancelmo Peter BVP, General CounselAug 28 '26Sale18.6525,000466,128200Sep 01 04:41 PM
Cancelmo Peter BVP, General CounselAug 31 '26Sale18.5425,000463,540200Sep 01 04:41 PM
PETER CANCELMOOfficerAug 31 '26Proposed Sale18.5425,000463,540Aug 31 04:21 PM
PETER CANCELMOOfficerAug 28 '26Proposed Sale18.6525,000466,128Aug 28 04:34 PM
HANISH ARNOLD CDirectorAug 27 '26Option Exercise14.9510,000149,47510,000Aug 28 04:31 PM
HANISH ARNOLD CDirectorAug 26 '26Option Exercise15.815,00079,0505,000Aug 28 04:31 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
BRNYBurney U.S. Factor Rotation ETFAUM: 576.79M
XPHState Street SPDR S&P Pharmaceuticals ETFAUM: 516.35M
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
BRESBurney U.S. Equity Select ETFAUM: 626.29M
VFMOVanguard U.S. Momentum Factor ETFAUM: 1.82B

News

latest 14 of 99

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-16-0.020--37.282
2026Q22026-08-120.150-0.2680.15028.5312.693
2026Q12026-05-130.620-0.3860.7809.934.194
2025Q42026-03-310.980-0.5700.9770.000.004
2025Q32025-11-13-0.470-0.447-0.4670.000.004
2025Q22025-08-14-0.430-0.503-0.4340.000.314
2025Q12025-05-15-0.580-0.566-0.5760.300.403
2024Q42025-03-31-0.540-0.776-0.5410.000.005
2024Q32024-11-13-0.560-0.705-0.5560.000.002
2024Q22024-08-07-0.970-1.138-0.9670.000.003
2024Q12024-05-15-0.630-0.561-0.6320.000.002
2023Q42024-04-01-0.150-0.555-0.1450.000.002
2023Q32023-11-09-0.600-0.614-0.6010.000.003
2023Q22023-08-09-0.590-0.570-0.5940.000.003
2023Q12023-05-09-0.540-0.530-0.5360.000.004
2022Q42023-03-132.050-0.5662.0510.000.004

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-1.710-1.520-1.706111.81110.18
2020FY-2.410-2.570-2.41573.8178.09
2021FY3.120-1.110-1.787110.74146.83
2022FY0.760-1.9600.7560.000.00
2023FY-1.880-2.275-1.8780.000.00
2024FY-2.700-2.933-2.6960.000.00
2025FY-0.050-2.033-0.0500.000.00
2026FY-0.825--127.51
2027FY-1.057--221.32
2028FY-1.614--317.96
2029FY-2.347--434.03
2030FY-3.030--518.93

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-10-2731037.2830.9040.60
2026Q3S2026-10-1533037.2830.9040.60
2026Q3S2026-10-1333037.2730.9040.60
2026Q3S2026-09-2133037.2830.9040.64
2026Q3S2026-08-1333036.7330.9040.30
2026Q3S2026-08-1230017.0013.0019.30
2026Q3S2026-07-2830017.0013.0019.30
2026Q3S2026-07-2233017.0013.0019.30
2026Q3S2026-06-2533017.0313.1019.30
2026Q3S2026-06-1133017.0313.1019.30
2026Q3S2026-05-2633017.0013.0019.30
2026Q3S2026-05-1443122.7513.0040.00
2026Q3S2026-04-2041119.462.8051.25
2026Q3S2026-04-0141031.142.8097.97

Estimate history

EPS, annual-1.174-2.609-1.706-2.415-1.7870.756-1.878-2.696-0.0531.4377
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.967-0.556-0.541-0.576-0.434-0.4670.9770.780.148
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual64.82629.868111.80500000038.42
Period201720182019202020212022202320242025TTM
Sales, quarterly00000009.89328.529
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual48.21149.01254.20161.67162.62962.82961.12958.04471.67172.088
Period201720182019202020212022202320242025MRQ
Shares, quarterly57.94457.9558.04458.06460.02270.07471.67171.99972.088
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue38.420.000.000.000.000.000.00111.8129.87
Cost of Goods Sold Incl. D&A2.300.960.950.920.951.391.622.650.99
Gross Profit36.12-0.96-0.95-0.92-0.95-1.39-1.62109.1528.88
Selling, General and Administrative Excl. Other108.94121.83168.31163.61162.44172.23155.30172.53141.10
Research and Development61.6881.30119.52114.87112.72118.78107.61109.7089.86
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-72.82-122.80-169.26-164.53-163.39-173.62-156.92-63.38-112.22
Interest Expense8.85-24.6830.8422.7019.6726.7522.6616.25
Unusual Expense45.13122.650.00-4.110.000.0013.370.0012.99
Net Income Before Taxes118.63-2.80-182.63-174.92-182.03-191.55-196.39-84.49-139.69
Income Taxes2.102.010.000.000.000.00-23.260.00-12.93
Consolidated Net Income116.53-4.81-182.63-174.92-182.03-191.55-173.13-84.49-126.76
Net Income From Continuing Operations116.53-4.81-182.63-174.92-182.03-191.55-173.13-84.49-126.76
Net Income124.83-3.35-156.81-117.8147.42-111.41-138.06-84.49-126.76
EPS (Recurring)1.751.30-2.70-1.920.76-1.79-2.25-1.71-2.42
EPS (Basic, Before Extraordinaries)1.72-0.05-2.70-1.880.76-1.79-2.41-1.71-2.61
EPS (Diluted)1.44-0.05-2.70-1.880.76-1.79-2.41-1.71-2.61
EBITDA-71.91-121.83-168.31-163.61-162.44-172.23-155.30-61.59-111.26
Non-Operating Income (Expense)245.43242.6511.3016.344.061.740.651.551.78
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense6.086.4710.4911.8914.1614.9510.0613.799.25
Price To Earnings Ratio12.0312.03-10.20-----
Price To Sales Ratio22.18-----11.076.2418.12
Gross Margin94.02------97.6396.68
Operating Margin-189.53-------56.69-375.73
Net Margin324.88-------75.57-424.39
Shares Outstanding72.0971.6758.0461.1362.8362.6361.6754.2049.01
Market Capitalization1,252.321,252.32572.54205.57141.77402.15880.70754.73545.96

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue28.539.890.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A1.000.830.230.240.200.290.300.24
Gross Profit27.539.07-0.23-0.24-0.20-0.29-0.30-0.24
Selling, General and Administrative Excl. Other27.4626.4928.8526.1532.1534.6835.3635.17
Research and Development13.6013.1219.2115.7621.8123.5623.0223.85
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income0.07-17.42-29.08-26.39-32.35-34.97-35.66-35.41
Interest Expense7.585.898.73-13.360.013.653.184.05
Unusual Expense-9.55-73.15119.008.82-5.240.000.000.00
Net Income Before Taxes6.6751.3181.90-21.24-25.89-37.56-36.54-37.11
Income Taxes0.030.062.010.000.000.000.000.00
Consolidated Net Income6.6451.2579.89-21.24-25.89-37.56-36.54-37.11
Net Income From Continuing Operations6.6451.2579.89-21.24-25.89-37.56-36.54-37.11
Net Income13.2356.0686.45-30.92-25.42-33.46-31.36-32.23
EPS (Recurring)0.070.071.92-0.37-0.50-0.58-0.54-0.56
EPS (Basic, Before Extraordinaries)0.180.781.22-0.47-0.43-0.58-0.54-0.56
EPS (Diluted)0.150.780.98-0.47-0.43-0.58-0.54-0.56
EBITDA0.27-17.18-28.85-26.15-32.15-34.68-35.36-35.17
Non-Operating Income (Expense)4.631.48238.710.621.241.062.302.35
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.281.491.371.942.062.452.432.64
Price To Earnings Ratio12.03-------
Price To Sales Ratio22.1876.77------
Gross Margin96.5091.65------
Operating Margin0.26-176.09------
Net Margin46.38566.66------
Shares Outstanding72.0972.0071.6770.0760.0258.0658.0457.95
Market Capitalization1,252.32748.711,217.72279.03175.78476.35572.54230.05

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments171.8090.13171.85194.92157.27134.9560.7960.5083.75
Short Term Receivables36.2736.8237.47242.0282.473.8435.1922.8217.14
Inventories0.000.000.000.000.000.001.150.090.44
Other Current Assets7.597.178.586.308.1512.496.626.467.04
Total Current Assets215.67134.12217.90443.24247.89151.28103.7589.87108.37
Net Property, Plant & Equipment12.4817.6420.5823.2530.0128.0830.913.852.12
Total Investments and Advances1.051.051.051.051.051.051.151.155.83
Long-Term Note Receivable96.44124.27138.74123.42140.250.00---
Intangible Assets0.000.000.000.000.000.000.000.000.00
Other Assets0.000.000.000.000.070.621.161.070.00
Total Assets325.63277.08378.27590.97419.27181.04136.9795.94116.33
Short Term Debt Incl. Current Port. of LT Debt43.9147.6213.7499.845.250.003.500.890.49
Accounts Payable4.765.917.715.9913.404.205.336.286.69
Income Tax Payable1.15--4.87-----
Other Current Liabilities28.2426.0031.8725.6833.1332.5446.6330.1919.13
Total Current Liabilities78.0679.5353.32136.3851.7936.7455.4637.3626.31
Long Term Debt363.10375.66347.85368.46342.58265.06190.53150.5684.12
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities----0.670.00---
Other Liabilities5.704.502.090.440.450.000.008.188.72
Total Liabilities446.86459.69403.25505.29395.49301.79245.99196.09119.14
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity-121.23-182.61-24.9885.6823.78-120.75-109.02-100.16-2.81
Total Shareholders Equity-121.23-182.61-24.9885.6823.78-120.75-109.02-100.16-2.81
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity-121.23-182.61-24.9885.6823.78-120.75-109.02-100.16-2.81
Total Liabilities & Stockholders Equity325.63277.08378.27590.97419.27181.04136.9795.94116.33
Book Value Per Share-1.69-3.15-0.411.360.38-1.96-2.01-2.04-0.06
Tangible Book Value Per Share-1.69-3.15-0.411.360.38-1.96-2.01-2.04-0.06
Full-Time Employees175202198196213277258236173
Price to Book Ratio-24.29-3.71-14.73-3.0616.93-7.30-7.00-5.45101.22
Return on Assets-1.60-55.73-36.09-36.04-63.82-108.88-72.55-119.43-58.26
Return on Equity---576.33-332.58-----
Return on Invested Capital-1.39-81.23-36.4910.44-30.41-95.67-103.65-251.49-65.78
Quick Ratio2.761.694.093.254.794.121.852.404.10
Current Ratio2.761.694.093.254.794.121.872.414.12

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income124.83-3.35-156.81-117.8147.42194.24-138.06-84.49-126.76
Depreciation0.910.960.950.920.951.391.621.790.96
Other Funds (Non Cash)-222.72-153.81-18.31-47.09-15.88-291.2440.7923.0230.70
Funds from Operations-96.98-156.19-178.54-172.7032.48-95.62-107.67-59.68-108.03
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital21.9333.7229.74247.42-118.97-14.117.58-0.394.29
Cash from Operating Activities-75.05-122.47-148.8074.73-86.48-109.72-100.09-60.07-103.74
Capital Expenditures-0.06-0.07-0.17-0.43-0.11-0.28-0.28-0.33-0.57
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses240.00240.000.000.000.00125.990.000.000.00
Purchase or Sale of Investments-103.12-75.4182.3827.88-127.4567.99-66.75-3.0730.40
Purchase of Investments-195.68-185.31-987.38-1,018.60-429.05-32.01-133.19-58.22-68.78
Sale Or Maturity of Investments92.55109.901,069.771,046.48301.59100.0066.4555.1599.18
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities136.82164.5282.2227.45-127.56193.71-67.03-3.4029.83
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock48.0946.99-11.30-4.500.418.3898.7061.846.73
Repurchase of Common Pref Stock-9.880.00-11.85-4.650.000.000.000.000.00
Sale of Common Pref Stock57.9746.990.550.150.418.3898.7061.846.73
Proceedsfrom Stock Options39.3439.340.000.000.000.0093.6754.240.00
Issuance or Reduction of Debt, Net-102.22-82.7874.19-101.58123.83-1.8291.41-1.14102.82
Change in Long Term Debt-102.22-82.7874.19-101.58123.83-1.8291.41-1.14102.82
Issuance of Long Term Debt0.000.00115.530.00125.000.00218.250.00247.75
Reduction of Long Term Debt-102.22-82.78-41.34-101.58-1.17-1.82-126.83-1.14-144.93
Net Financing Active Other Cash Flow-7.560.000.000.000.00-0.24-15.570.00-33.18
Other Financing Activities Uses-1.270.000.000.000.00-0.24-23.220.00-33.18
Cash from Financing Activities-61.68-35.7962.88-106.08124.256.32174.5360.7076.37
Net Change in Cash0.086.26-3.71-3.90-89.8090.317.42-2.782.47
Free Cash Flow-75.11-122.54-148.9774.30-86.60-110.00-100.37-60.41-104.30
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow---2.76-----
Deferred Taxes & Investment Tax Credit-0.00-4.37-8.710.000.00-12.010.00-12.93

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments131.95135.32171.8036.0928.7452.41
Short Term Receivables46.9037.5136.2731.9634.5036.30
Inventories0.840.180.000.000.000.00
Other Current Assets5.547.357.593.766.417.47
Total Current Assets185.24180.35215.6771.8169.6596.18
Net Property, Plant & Equipment9.6611.0512.4813.8215.1316.37
Total Investments and Advances1.051.051.051.051.051.05
Intangible Assets0.000.000.000.000.000.00
Other Assets0.000.000.000.000.000.00
Total Assets286.83286.17325.63185.71200.57235.16
Short Term Debt Incl. Current Port. of LT Debt59.3526.2743.9142.5142.7654.06
Accounts Payable6.345.374.7612.508.844.41
Income Tax Payable0.661.151.15---
Other Current Liabilities28.6126.6628.2425.7533.9024.75
Total Current Liabilities94.9659.4478.0680.7685.5083.22
Long Term Debt237.52284.36363.10320.93339.25360.99
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities5.705.705.704.504.504.50
Total Liabilities338.18349.51446.86406.18429.25448.71
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity-51.35-63.33-121.23-220.48-228.69-213.55
Total Shareholders Equity-51.35-63.33-121.23-220.48-228.69-213.55
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity-51.35-63.33-121.23-220.48-228.69-213.55
Total Liabilities & Stockholders Equity286.83286.17325.63185.71200.57235.16
Book Value Per Share-0.71-0.88-1.69-3.15-3.81-3.68
Tangible Book Value Per Share-0.71-0.88-1.69-3.15-3.81-3.68
Full-Time Employees--175---
Price to Book Ratio-24.29-6.24-5.46-1.08-0.82-2.61
Return on Assets47.8232.23-1.60-48.59-49.24-52.43
Return on Invested Capital7.1125.3635.74-30.78-22.99-22.69
Quick Ratio1.943.032.760.890.811.16
Current Ratio1.953.032.760.890.811.16

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income13.2356.0686.45-30.92-25.42-33.46
Depreciation0.190.240.230.240.200.29
Other Funds (Non Cash)-12.57-75.96-132.34-1.84-15.05-4.57
Funds from Operations0.85-19.66-45.66-32.52-40.28-37.74
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital3.295.15-0.5714.0518.341.90
Cash from Operating Activities4.15-14.51-46.22-18.47-21.94-35.84
Capital Expenditures-0.040.000.00-0.01-0.01-0.04
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.00240.000.000.000.00
Purchase or Sale of Investments3.4428.73-128.45-6.8521.3138.58
Purchase of Investments-10.15-1.32-166.85-17.35-0.39-0.72
Sale Or Maturity of Investments13.6030.0538.4010.5021.7039.30
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities3.4028.73111.55-6.8621.3038.54
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-2.874.0611.0635.840.030.06
Repurchase of Common Pref Stock-5.73-4.150.000.000.000.00
Sale of Common Pref Stock2.868.2111.0635.840.030.06
Proceedsfrom Stock Options0.000.003.7235.620.000.00
Issuance or Reduction of Debt, Net-4.60-21.93-71.96-3.73-5.19-1.90
Change in Long Term Debt-4.60-21.93-71.96-3.73-5.19-1.90
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-4.60-21.93-71.96-3.73-5.19-1.90
Net Financing Active Other Cash Flow0.00-4.112.84-6.293.450.00
Other Financing Activities Uses0.00-4.112.840.00-2.840.00
Cash from Financing Activities-7.47-21.98-58.0625.82-1.72-1.84
Net Change in Cash0.08-7.757.260.49-2.360.86
Free Cash Flow4.10-14.51-46.22-18.48-21.95-35.88

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3018.52%12.8M69.3M1.67M
2026-10-1516.50%11.4M69.3M1.71M
2026-09-3016.43%11.4M69.3M1.77M
2026-09-1518.03%12.5M69.3M1.95M
2026-08-3118.41%12.8M69.3M2.08M
2026-08-1421.13%14.6M69.3M2.11M
2026-07-3122.09%15.4M69.8M1.84M
2026-07-1521.62%15.1M69.8M1.78M
2026-06-3021.69%15.1M69.8M1.81M
2026-06-1525.94%18.1M69.8M1.50M
2026-05-2923.32%16.3M69.8M1.27M
2026-05-1522.89%15.9M69.6M1.14M
2026-04-3022.81%15.8M69.2M1.06M
2026-04-1524.41%16.9M69.2M1.14M
2026-03-3124.66%17.1M69.2M1.47M
2026-03-1325.39%17.3M68.2M2.26M
2026-02-2725.36%17.3M68.2M2.33M
2026-02-1326.34%18.0M68.2M2.52M
2026-01-3025.89%17.7M68.2M2.58M
2026-01-1524.08%16.4M68.2M2.80M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call1.0015.0018.9017.550.0003.000.000.996-0.0160.000
call2.0013.6017.908.4025.5870.000.000.995-0.0180.000
call3.0012.6017.000.0017.2700.000.000.980-0.0660.001
call4.0011.6016.000.0013.6150.000.000.974-0.0670.002
call5.0010.6014.906.9011.0653.000.000.969-0.0680.002
call6.009.6013.900.009.5320.000.000.954-0.0890.003
call7.009.0012.503.396.9150.000.000.957-0.0670.003
call8.008.0011.504.506.09410.000.000.950-0.0660.003
call9.007.0010.109.614.56317.000.000.942-0.0640.003
call10.006.009.507.205.1122100.000.918-0.0830.004
call11.004.709.001.755.28326.000.000.906-0.0800.005
call12.005.407.205.303.5421,0440.000.892-0.0770.005
call13.003.006.604.763.61581.000.000.875-0.0730.006
call14.002.006.103.603.7291340.000.853-0.0690.006
call15.001.504.404.502.4605360.000.765-0.1110.009
call16.001.953.601.852.2431,0610.000.714-0.1100.010
call17.001.502.752.121.9491,2736.000.650-0.1010.010
call18.001.002.201.601.8931,5266.000.574-0.1260.011
call19.001.001.701.751.8201,5281450.502-0.1260.011
call20.000.401.850.801.3101,38218.000.356-0.0790.011
call21.000.000.650.651.4099807.000.291-0.0780.010
call22.000.150.700.401.6248706.000.264-0.0850.009
call23.000.100.300.251.3791,4611060.161-0.0540.007
call24.000.050.950.151.53899.000.000.148-0.0570.007
call25.000.050.200.101.5115410.000.107-0.0450.005
call26.000.050.400.141.6403.000.000.101-0.0460.005
call27.000.000.250.151.76220.000.000.095-0.0480.005
call28.000.002.200.001.88250.000.000.091-0.0490.005
call29.000.003.000.051.98720.000.000.087-0.0510.004
call30.000.001.000.052.0911130.000.084-0.0520.004
call31.000.001.000.002.1890.000.000.081-0.0530.004
call32.000.001.000.002.2840.000.000.079-0.0540.004
put1.000.000.050.008.9910.000.00-0.004-0.0150.000
put2.000.000.050.006.6290.000.00-0.006-0.0160.000
put3.000.001.000.038.2631.000.00-0.020-0.0650.001
put4.000.001.000.106.9213.000.00-0.026-0.0670.002
put5.000.000.500.106.6176.000.00-0.039-0.0880.002
put6.000.001.150.045.1467.000.00-0.037-0.0670.002
put7.000.001.150.605.02471.000.00-0.054-0.0870.003
put8.000.001.150.104.41186.000.00-0.062-0.0860.003
put9.000.001.150.353.8751170.00-0.071-0.0840.004
put10.000.001.150.053.3986810.00-0.082-0.0820.004
put11.000.001.150.052.9652130.00-0.094-0.0790.005
put12.000.001.150.122.56723.000.00-0.108-0.0760.005
put13.000.001.150.272.19641.000.00-0.125-0.0720.006
put14.000.000.450.331.84553.000.00-0.147-0.0670.006
put15.000.001.050.402.2492000.00-0.235-0.1100.009
put16.000.501.200.632.0018301.00-0.286-0.1080.010
put17.000.401.250.981.63114824.00-0.350-0.0990.010
put18.000.802.251.552.0901950.00-0.426-0.1240.011
put19.001.103.101.502.3256520.00-0.498-0.1230.011
put20.001.103.603.122.19565.000.00-0.644-0.0760.011
put21.001.654.502.822.37827.000.00-0.709-0.0750.010
put22.003.505.203.302.3421340.00-0.736-0.0830.009
put23.003.507.500.003.7500.000.00-0.839-0.0510.007
put24.005.408.500.003.9590.000.00-0.852-0.0540.007
put25.006.009.500.004.1530.000.00-0.893-0.0420.005
put26.006.2010.500.004.3330.000.00-0.899-0.0440.005
put27.008.1011.500.004.3200.000.00-0.905-0.0450.005
put28.009.0011.300.003.5200.000.00-0.909-0.0460.005
put29.0010.2012.700.004.0610.000.00-0.913-0.0470.004
put30.0010.1014.400.004.8630.000.00-0.916-0.0480.004
put31.0012.2015.400.004.9980.000.00-0.919-0.0490.004
put32.0012.6016.400.005.1260.000.00-0.921-0.0500.004

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-308-KCurrent report2026-10-28SEC
2026-10-304Statement of changes in beneficial ownership of securities2026-10-28SEC
2026-09-244Statement of changes in beneficial ownership of securities2026-09-22SEC
2026-09-23144Filing for proposed sale of securities under Rule 144.SEC
2026-09-22144Filing for proposed sale of securities under Rule 144.SEC
2026-09-014Statement of changes in beneficial ownership of securities2026-08-28SEC
2026-08-31144Filing for proposed sale of securities under Rule 144.SEC
2026-08-28144Filing for proposed sale of securities under Rule 144.SEC
2026-08-284Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-08-27144Filing for proposed sale of securities under Rule 144.SEC
2026-08-26144Filing for proposed sale of securities under Rule 144.SEC
2026-08-254Statement of changes in beneficial ownership of securities2026-08-21SEC
2026-08-21144Filing for proposed sale of securities under Rule 144.SEC
2026-08-214Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-20144Filing for proposed sale of securities under Rule 144.SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-183Initial statement of beneficial ownership of securities2026-08-12SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-13144Filing for proposed sale of securities under Rule 144.SEC
2026-08-13S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-08-138-KCurrent report2026-08-12SEC
2026-08-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-128-KCurrent report2026-08-12SEC
2026-07-29SCHEDULE 13G/ASEC
2026-07-244Statement of changes in beneficial ownership of securities2026-07-22SEC
2026-07-244Statement of changes in beneficial ownership of securities2026-07-22SEC
2026-07-244Statement of changes in beneficial ownership of securities2026-07-22SEC
2026-07-208-KCurrent report2026-07-20SEC
2026-07-068-KCurrent report2026-07-02SEC
2026-06-258-KCurrent report2026-06-18SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-0900419.00K2
2026-08001.78M8
2026-070000
2026-060000
2026-050087.04K1
2026-040000
2026-030000
2026-020000
2026-0100750.92K2
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.8.35%
INGALLS & SNYDER LLC5.06%
VANGUARD CAPITAL MANAGEMENT LLC4.24%
UBS Group AG4.10%
STATE STREET CORP3.21%
GEODE CAPITAL MANAGEMENT, LLC2.62%
STIFEL FINANCIAL CORP2.54%
VANGUARD PORTFOLIO MANAGEMENT LLC1.33%
Invesco Ltd.1.04%
NORTHERN TRUST CORP1.00%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND3.00%
iShares Russell 2000 ETF2.59%
VANGUARD EXTENDED MARKET INDEX FUND1.15%
Fidelity Small Cap Index Fund1.09%
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF0.89%
Invesco Biotechnology & Genome ETF0.83%
iShares Russell 2000 Value ETF0.58%
VANGUARD RUSSELL 2000 INDEX FUND0.57%
Fidelity Extended Market Index Fund0.49%
Schwab U.S. Small-Cap ETF0.48%

OakChart. OMER. Cached 15 minutes.